메뉴 건너뛰기




Volumn 35, Issue 3, 2001, Pages 432-433

Steatosis in chronic hepatitis C: Can weight reduction improve therapeutic efficacy? (multiple letters)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT;

EID: 0034857085     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(01)00107-6     Document Type: Letter
Times cited : (30)

References (11)
  • 2
    • 0032873596 scopus 로고    scopus 로고
    • Steatosis and bile duct damage in chronic hepatitis C: distribution and relationships in a group of Northern Italian patients
    • E Giannini P Ceppa F Botta A Fasoli P Romagnoli E Cresta Steatosis and bile duct damage in chronic hepatitis C: distribution and relationships in a group of Northern Italian patients Liver 19 1999 432 437
    • (1999) Liver , vol.19 , pp. 432-437
    • Giannini, E1    Ceppa, P2    Botta, F3    Fasoli, A4    Romagnoli, P5    Cresta, E6
  • 3
    • 0032030819 scopus 로고    scopus 로고
    • Reduction in hepatic cytochrome P-450 is correlated to the degree of liver fat content in animal models of steatosis in the absence of inflammation
    • I Leclercq Y Horsmans J-P Desager N Delzenne A-P Geubel Reduction in hepatic cytochrome P-450 is correlated to the degree of liver fat content in animal models of steatosis in the absence of inflammation J Hepatol 28 1998 410 416
    • (1998) J Hepatol , vol.28 , pp. 410-416
    • Leclercq, I1    Horsmans, Y2    Desager, J-P3    Delzenne, N4    Geubel, A-P5
  • 4
    • 0029011134 scopus 로고
    • Hepatic lidocaine metabolism in chronic hepatitis C virus hepatitis with or without steatosis
    • G Taliani F Duca R Lecce D Livoli C Pasquazzi C De Bac Hepatic lidocaine metabolism in chronic hepatitis C virus hepatitis with or without steatosis Hepatology 21 1995 1760 1761
    • (1995) Hepatology , vol.21 , pp. 1760-1761
    • Taliani, G1    Duca, F2    Lecce, R3    Livoli, D4    Pasquazzi, C5    De Bac, C6
  • 5
    • 4243376310 scopus 로고    scopus 로고
    • Liver steatosis and response to interferon alpha in patients with chronic hepatitis C.[Abstract]
    • H Wedemeyer H Frank C Trautwein A Schiler P Flemming E Jackel Liver steatosis and response to interferon alpha in patients with chronic hepatitis C.[Abstract] Hepatology 28 1998 569A
    • (1998) Hepatology , vol.28 , pp. 569A
    • Wedemeyer, H1    Frank, H2    Trautwein, C3    Schiler, A4    Flemming, P5    Jackel, E6
  • 6
    • 0033762069 scopus 로고    scopus 로고
    • Leptin has no role in determining severity of steatosis and fibrosis in patients with chronic hepatitis C
    • E Giannini P Ceppa F Botta L Mastracci P Romagnoli I Comino Leptin has no role in determining severity of steatosis and fibrosis in patients with chronic hepatitis C Am J Gastroenterol 95 2000 3211 3217
    • (2000) Am J Gastroenterol , vol.95 , pp. 3211-3217
    • Giannini, E1    Ceppa, P2    Botta, F3    Mastracci, L4    Romagnoli, P5    Comino, I6
  • 7
    • 4243949764 scopus 로고    scopus 로고
    • Effect of antiviral therapy treatment on the evolution of steatosis in patients with chronic hepatitis C (CHC) and serial liver biopsies. [Abstract]
    • L Castera C Hezode A Bastie F Roudot-Thoraval E.-S Zafrani J.-M Pawlotsky Effect of antiviral therapy treatment on the evolution of steatosis in patients with chronic hepatitis C (CHC) and serial liver biopsies. [Abstract] Hepatology 32 2000 363A
    • (2000) Hepatology , vol.32 , pp. 363A
    • Castera, L1    Hezode, C2    Bastie, A3    Roudot-Thoraval, F4    Zafrani, E.-S5    Pawlotsky, J.-M6
  • 9
    • 0033933140 scopus 로고    scopus 로고
    • Hepatocyte steatosis is a cytopathic effect of hepatitis C virus genotype 3
    • L Rubbia-Brandt R Quadri K Abid E Giostra P.J Male G Mentha Hepatocyte steatosis is a cytopathic effect of hepatitis C virus genotype 3 J Hepatol 33 2000 106 115
    • (2000) J Hepatol , vol.33 , pp. 106-115
    • Rubbia-Brandt, L1    Quadri, R2    Abid, K3    Giostra, E4    Male, P.J5    Mentha, G6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.